Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nanchen

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
International Journal of Cardiology|March 23, 2023
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbiditiesAndrea Denegri, Giulia Magnani, Simon Kraler, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 25, 2023
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-studyMichael A Matter, Alessandro Candreva, Barbara E Stähli, et al.
International Journal of Cardiology|December 21, 2019
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortBaris Gencer, David Carballo, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
Open Heart|June 3, 2016
Health utility indexes in patients with acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Circulation|July 28, 2016
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesDavid Nanchen, Baris Gencer, Olivier Muller, et al.
European Heart Journal. Acute Cardiovascular Care|June 5, 2018
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
Atherosclerosis|January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesBaris Gencer, Reto Auer, David Nanchen, et al.
European Journal of Clinical Investigation|July 27, 2025
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromesMaëlle Achard, Cédric Follonier, Evelyne Fournier, et al.
Journal of the American Heart Association|November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary SyndromesBaris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
International Journal of Cardiology|March 23, 2023
History of peripheral artery disease and cardiovascular risk of real-world patients with acute coronary syndrome: Role of inflammation and comorbiditiesAndrea Denegri, Giulia Magnani, Simon Kraler, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 25, 2023
Higher 1-year mortality on rest days in patients with acute coronary syndromes and decompensated heart failure-A SPUM-ACS sub-studyMichael A Matter, Alessandro Candreva, Barbara E Stähli, et al.
International Journal of Cardiology|December 21, 2019
Intensified lipid lowering using ezetimibe after publication of the IMPROVE-IT trial: A contemporary analysis from the SPUM-ACS cohortBaris Gencer, David Carballo, David Nanchen, et al.
European Heart Journal. Acute Cardiovascular Care|December 29, 2016
Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the GRACE scoreRoland Klingenberg, Soheila Aghlmandi, Lorenz Räber, et al.
Open Heart|June 3, 2016
Health utility indexes in patients with acute coronary syndromesBaris Gencer, Nicolas Rodondi, Reto Auer, et al.
Circulation|July 28, 2016
Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary SyndromesDavid Nanchen, Baris Gencer, Olivier Muller, et al.
European Heart Journal. Acute Cardiovascular Care|June 5, 2018
Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort studyBaris Gencer, Fabio Rigamonti, David Nanchen, et al.
Atherosclerosis|January 14, 2015
Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromesBaris Gencer, Reto Auer, David Nanchen, et al.
European Journal of Clinical Investigation|July 27, 2025
Educational level, clinical outcomes and quality of care in a Swiss cohort of patients with acute coronary syndromesMaëlle Achard, Cédric Follonier, Evelyne Fournier, et al.
Journal of the American Heart Association|November 11, 2017
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary SyndromesBaris Gencer, Konstantinos C Koskinas, Lorenz Räber, et al.
Pageof 14